Breakthrough Cancer Research: UNT Health Science Center Faculty Secure Patents for Novel Treatments

(from left to right) Kyle Emmitte, PhD and Jin Liu, PhD

Two faculty members from The University of North Texas Health Science Center, Dr. Kyle Emmitte and Dr. Jin Liu, collaborated on a project targeting cancer treatment. Their computational approach led to a patent approval, validating their innovative molecular design methodology. Supported by former faculty member Jack Wang, they combined wet lab chemistry with molecular modeling to develop novel anti-cancer molecules. Published in the British Journal of Cancer, their findings showcase the power of interdisciplinary research. Emmitte emphasized teamwork's importance, and Liu's additional patent for CRISPR-Cas9 technology underscores their commitment to healthcare advancement. These patents hold promise for revolutionizing cancer treatment and genetic disorder interventions, offering hope beyond academia.